Hydrocortisone

  • Description and indication for use

    Hydrocortisone is the main adrenal corticosteroid and has mainly glucocorticoid effects. These include enhancement of vascular reactivity to vasoactive substances, stimulation of the production of glucose in the liver, and increased deposition of glucose as Glycogen. Hydrocortisone also decreases peripheral glucose utilisation, and increases protein breakdown and lipolysis. It also has anti-inflammatory and immunosuppressive properties.

    Hydrocortisone is used as steroid replacement in adrenal insufficiency, and in the treatment of refractory hypotension and hypoglycaemia.

    Dose

    Early Neonatal Hypotension

    IV:

    2 mg/kg/dose stat, then 1 mg/kg/dose 8 to12-hourly.

    Acute adrenal insufficiency

    IV:

    1 to 2 mg/kg/dose stat, then 1 to 2 mg/kg/dose 6-hourly.

    Congenital Adrenal Hyperplasia

    IV:

    0.5 to 0.7 mg/kg/DAY in divided doses initially, then adjust dose according to response.

    Anti-inflammatory

    IV AND IM:

    2.5 mg/kg/dose 6-hourly.

    Do not cease suddenly if given in high doses for longer than two weeks.

    Reconstitution/Dilution

    Vial = 100 mg.

    IV:

    To reconstitute 100 mg vial, add 2 mL of water for injection to vial = 100 mg in 2 mL = 50 mg/mL.

    Dilute as required to measure dose:

    For dilution to 1 mg/mL:

    Withdraw 0.2 mL of 50 mg/mL solution from vial and add to 9.8 mL of sodium chloride 0.9% in a 10 mL syringe = 10 mg in 10 mL = 1 mg/mL.

    For dilution to 5 mg/mL:

    Withdraw 1 mL of 50 mg/mL solution from vial and add to 9 mL of sodium chloride 0.9% in a 10 mL syringe = 50 mg in 10 mL = 5 mg/mL.

    Route and method of administration

    IV:

    Give by slow IV push over at least 5 minutes. Flush with sodium chloride 0.9%.

    Contraindications

    Untreated systemic bacterial infection.

    Systemic fungal infection.

    CAUTION in hypertension.

    CAUTION in hyperglycaemia.

    Drug interactions

    Frusemide, Hydrochlorothiazide, Liposomal Amphotericin B Combination may result in excessive potassium loss, resulting in hypokalaemia.
    Pancuronium Antagonism of neuromuscular blockade.
    Phenobarbitone, Phenytoin, Rifampicin Decreased plasma levels and therapeutic effect of hydrocortisone due to increased metabolism.
    Indomethacin Increased risk of gut perforation.

                                                                

Disclaimer:  This Drug information was designed for use by PIPER Neonatal. Whilst great care has been taken to check the information is accurate, it is possible that errors may have been missed. Furthermore, dosage schedules are continually being revised and new side effects recognised. For these reasons, the reader is strongly advised to consult the drug companies' printed information before administering any of the drugs recommended in this book.
Most drugs in this document are appropriate only for specialist use in hospitals.  A number of drugs should only be used in consultation with the appropriate Paediatric subspecialist. 

Note: The electronic version of this guideline is the version currently in use.  Any printed version cannot be assumed to be current. Printed copies of this document are valid for